A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
Clinical trial NCT03331562 · COMPLETED
Trial details
- NCT number
- NCT03331562
- Sponsor
- Translational Genomics Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-27
- Primary completion
- 2020-06-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.